Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Anthony Smith: Mental Health during Christmas and new year festivities
The holidays are often called 'the most wonderful time of the year,' but they can also bring stress, anxiety, and ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 12:29 — 17.1MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Dr Verity Truelove: Apps and Road Safety
Navigation apps are great for working out the best way to navigate, but they also play a role in road ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 6:07 — 8.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Tim Hunter: Kultcha
Find out what’s on Melbourne with Tim Hunter. In this podcast, Tim talks about: - One Day in September – ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 10:37 — 14.6MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS